TickerFacts.

Incyte Corp (INCY): Share Repurchases

Annual figures by period end, from SEC filings.

$0
Year ended 2025-12-31
$2.00B2022-12-31: $02023-12-31: $02024-12-31: $2.00B2025-12-31: $0$0
2022-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$0-100.0%2026-02-10, From 2025-01-01
2024-12-31$2.00Bn/a2026-02-10, From 2024-01-01
2023-12-31$0n/a2026-02-10, From 2023-01-01
2022-12-31$0n/a2025-02-10, From 2022-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Incyte Corp (INCY)2025-12-31$0-100.0%
Charles River Laboratories International, Inc. (CRL)2025-12-27$360.67M+202.6%
Icon PLC (ICLR)2025-12-31$750.00M+50.0%
Medpace Holdings, Inc. (MEDP)2025-12-31$917.39M+440.1%
Iqvia Holdings Inc. (IQV)2025-12-31$1.24B-7.9%
NRC Health (NRC)2025-12-31$20.18M-34.8%
IB Acquisition Corp. (IBAC)2025-09-30$106.13Mn/a

Compare INCY, CRL, ICLR, MEDP side by side · Screen every company in Services-Commercial Physical & Biological Research ↗